TY - JOUR
T1 - Identification of an altered matrix signature in kidney aging and disease
AU - Randles, Michael J.
AU - Lausecker, Franziska
AU - Kong, Qingyang
AU - Suleiman, Hani
AU - Reid, Graeme
AU - Kolatsi-Joannou, Maria
AU - Davenport, Bernard
AU - Tian, Pinyuan
AU - Falcone, Sara
AU - Potter, Paul
AU - van Agtmael, Tom
AU - Norman, Jill T.
AU - Long, David A.
AU - Humphries, Martin J.
AU - Miner, Jeffrey H.
AU - Lennon, Rachel
N1 - Funding Information:
Dr. David Knight and Dr. Stacey Warwood for advice and technical support and Mr. Julian Selley for bioinformatic support. Special thanks goes to Dr. Peter March and Mr. Roger Meadows for their help with the microscopy. The authors thank the staff in the Electron Microscopy Core Facility in the Faculty of Biology, Medicine and Health for their assistance. Special thanks goes to Dr. Aleksandr Mironov and Dr. Tobias Starborgand the Wellcome Trust for equipment grant support to the Electron Microscopy Core Facility.
Funding Information:
This work was supported by Wellcome Trusthttps://doi.org/10.13039/ 100004440 Senior Fellowship Award 202860/Z/16/Z (to R. Lennon) and grant 092015 (to M.J. Humphries), Kidney Research UK https://doi.org/ 10.13039/501100000291 grant RP52/2014 (awarded to R. Lennon and J.H. Miner to support a postdoctoral research assistant position for M.J. Ran-dles), and Cancer Research UK https://doi.org/10.13039/501100000289 grant C13329. D.A. Long’s laboratory is supported by Medical Research Council https://doi.org/10.13039/501100000265 grant MR/P018629/1; Diabetes UK https://doi.org/10.13039/501100000361 grants 13/0004763, 15/ 0005283, and 17/0005733; Kidney Research UKhttps://doi.org/10.13039/ 501100000291 grant RP36/2015; and by the NIHR Imperial Biomedical Research Centre https://doi.org/10.13039/501100013342 at Great Ormond Street Hospital for Children https://doi.org/10.13039/501100003784 University College London Hospitals NHS Foundation Trusthttps://doi.org/ 10.13039/501100008721.T. Van Agtmael’s laboratory is supported by Kidney Research UK https://doi.org/10.13039/501100000291 grant RP 19/2012, British Heart Foundation https://doi.org/10.13039/501100000274 grant PG/ 15/92/31813, and Medical Research Councilhttps://doi.org/10.13039/ 501100000265 grant MR/R005567-1. The authors also acknowledge Wellcome Trust https://doi.org/10.13039/100004440 core funding under grant 203128/Z/16/Z to the Wellcome Centre for Cell-Matrix Research at the University of Manchester.
Funding Information:
The mass spectrometer and microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the University of Manchester Strategic Fund.
Funding Information:
M.J. Humphries reports having consultancy agreements with Alpha-5; receiving honoraria from the Biotechnology and Biological Sciences Research Council; and serving as a scientific advisor for, or member of, the Biotechnology and Biological Sciences Research Council, Journal of Cell Biology, Journal of Cell Science, and Matrix Biology. R. Lennon reports serving as a trustee for Alport UK and Kidneys for Life; serving on the Scientific Advisor Research Network for the Alport Syndrome Foundation and on the Kidney Research UK grants panel; receiving studentship funding from GlaxoSmithKline; having other interests in/relationships with Kidney Research UK; serving as a consultant for, and having consultancy agreements with, Travere Therapeutics; and receiving funding from the Wellcome Trust. D.A. Long reports serving as an editorial board member of JASN and as an academic editor for PLOS One; and having a patent held with UCL Business related to vascular endothelial growth factor C therapy in polycystic kidney disease (JP6261617). J.H. Miner reports having consultancy agreements with Alpha Insights, Bridge Bio, Deerfield Management, Jans-sen Biotech Inc., Mantra Bio, and The Planning Shop; serving as the president-elect of the American Society for Matrix Biology; having patents and inventions with Angion, Kerafast, and Maze Therapeutics; receiving honoraria from the Japanese Society of Pharmacology and University of Kansas Medical Center; and serving as a consulting editor for the Journal of Clinical Investigation and on the editorial board of Kidney International, Matrix Biology, and Matrix Biology Plus. J.T. Norman reports receiving studentship funding from AstraZeneca and UCB; and serving as associate editor for BMC Nephrology, associate editor for the European Journal of Clinical Investigation, as a committee member of the Kidney Research UK Research Strategy Committee, as a trustee of Kidney Research UK, as a committee member of Medical Research Council Genetically Engineered Mice for Medicine, on the editorial board for Nature Scientific Reports, and as cochair of the UK Renal Fibrosis Network. T. Van Agtmael reports serving on the editorial board of the journal Bioscience Reports and the editorial board for the cardiovascular therapeutics section of the journal Frontiers in Cardiovascular Medicine. All remaining authors have nothing to disclose.
Publisher Copyright:
© 2021 by the American Society of Nephrology
PY - 2021/7
Y1 - 2021/7
N2 - Background Accumulation of extracellular matrix in organs and tissues is a feature of both aging and disease. In the kidney, glomerulosclerosis and tubulointerstitial fibrosis accompany the decline in function, which current therapies cannot address, leading to organ failure. Although histologic and ultrastructural patterns of excess matrix form the basis of human disease classifications, a comprehensive molecular resolution of abnormal matrix is lacking. Methods Using mass spectrometry-based proteomics, we resolved matrix composition over age in mouse models of kidney disease. We compared the changes in mice with a global characterization of human kidneymatrix during aging and to existing kidney disease datasets to identify common molecular features. Results Ultrastructural changes in basement membranes are associated with altered cell adhesion and metabolic processes and with distinct matrix proteomes during aging and kidney disease progression in mice. Within the altered matrix, basement membrane components (laminins, type IV collagen, type XVIII collagen) were reduced and interstitial matrix proteins (collagens I, III, VI, and XV; fibrinogens; and nephronectin) were increased, a pattern also seen in human kidney aging. Indeed, this signature of matrix proteins was consistently modulated across all age and disease comparisons, and the increase in interstitial matrix was also observed in human kidney disease datasets. Conclusions This study provides deep molecular resolution of matrix accumulation in kidney aging and disease, and identifies a common signature of proteins that provides insight into mechanisms of response to kidney injury and repair.
AB - Background Accumulation of extracellular matrix in organs and tissues is a feature of both aging and disease. In the kidney, glomerulosclerosis and tubulointerstitial fibrosis accompany the decline in function, which current therapies cannot address, leading to organ failure. Although histologic and ultrastructural patterns of excess matrix form the basis of human disease classifications, a comprehensive molecular resolution of abnormal matrix is lacking. Methods Using mass spectrometry-based proteomics, we resolved matrix composition over age in mouse models of kidney disease. We compared the changes in mice with a global characterization of human kidneymatrix during aging and to existing kidney disease datasets to identify common molecular features. Results Ultrastructural changes in basement membranes are associated with altered cell adhesion and metabolic processes and with distinct matrix proteomes during aging and kidney disease progression in mice. Within the altered matrix, basement membrane components (laminins, type IV collagen, type XVIII collagen) were reduced and interstitial matrix proteins (collagens I, III, VI, and XV; fibrinogens; and nephronectin) were increased, a pattern also seen in human kidney aging. Indeed, this signature of matrix proteins was consistently modulated across all age and disease comparisons, and the increase in interstitial matrix was also observed in human kidney disease datasets. Conclusions This study provides deep molecular resolution of matrix accumulation in kidney aging and disease, and identifies a common signature of proteins that provides insight into mechanisms of response to kidney injury and repair.
UR - http://www.scopus.com/inward/record.url?scp=85114064034&partnerID=8YFLogxK
U2 - 10.1681/ASN.2020101442
DO - 10.1681/ASN.2020101442
M3 - Article
C2 - 34049963
AN - SCOPUS:85114064034
SN - 1046-6673
VL - 32
SP - 1713
EP - 1732
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 7
ER -